Surgical management of colorectal cancer liver metastases Review
| Authors: | Padmanabhan, C.; Nussbaum, D. P.; D'Angelica, M. |
| Review Title: | Surgical management of colorectal cancer liver metastases |
| Abstract: | Approximately 50% of colorectal cancer patients develop liver metastases. Hepatic metastases represent the most common cause of colorectal cancer-related mortality. Metastasectomy, if possible, represents the most effective treatment strategy; 20% of patients will be cured and more than 50% survive at least 5 years. Nuances to treatment planning hinge on whether patients present with resectable disease upfront, whether the future liver remnant is adequate, and whether the primary tumor, if present, is colon versus rectal in origin. This article discusses considerations impacting our approach to patients with colorectal liver metastases and the role for various multimodal treatment options. © 2020 Elsevier Inc. |
| Keywords: | colorectal cancer; colon cancer; rectal cancer; liver metastases |
| Journal Title: | Surgical Oncology Clinics of North America |
| Volume: | 30 |
| Issue: | 1 |
| ISSN: | 1055-3207 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-01-01 |
| Start Page: | 1 |
| End Page: | 25 |
| Language: | English |
| DOI: | 10.1016/j.soc.2020.09.002 |
| PUBMED: | 33220799 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review; Book Chapter in D'Angelica M, ed. "Management of Metastatic Liver Tumors" (ISBN: 978-0-323-76449-0) -- Export Date: 4 January 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
781D'Angelica -
4Nussbaum
Related MSK Work